DRUG · Unmapped registry intervention
SGLT-2 inhibitor
Find medicine records ·
Find other trials using this name
Clinical trial
Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors
NCT06753994
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedContinuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetesverified · MONDO: diabetes mellitus
Type1diabetesunresolved
T1Dverified · MONDO: type 1 diabetes mellitus
Interventions
SGLT-2 inhibitorDRUG
Sponsors & collaborators
McGill Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06753994 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.